Table 1 Intathecal drugs administered to “control” and “strychnine” rat treatment groups during baseline, pre-dizocilpine, and dizocilpine MAC measurement periods
From: Increased NMDA receptor inhibition at an increased Sevoflurane MAC
Group | Baseline | Pre-Dizocilpine | Dizocilpine |
|---|---|---|---|
Control | no infusion | aCSF+CO2 | aCSF +CO2 + dizocilpine |
Strychnine | no infusion | aCSF+CO2 + strychnine | aCSF + CO2 + strychnine +dizocilpine |